Business Context and Reporting Period
This Form 8-K filing by Praxis Precision Medicines, Inc. (PRAX) reports a corporate action effective November 28, 2023. The Company, incorporated in Delaware and headquartered in Boston, Massachusetts, is an emerging growth company trading on The Nasdaq Global Select Market.
Key Financial Metrics
This filing does not contain new revenue, profit, cash flow, margin, debt, or liquidity figures. Instead, it provides updated historical financial data adjusted for a reverse stock split. The filing references previously filed reports (10-K and 10-Q) for the years ended December 31, 2022 and 2021, and various quarters through September 30, 2023, noting that the data has been restated to reflect the split.
Material Changes
- Reverse Stock Split: The Company executed a 1-for-15 reverse stock split effective at 5:00 p.m. Eastern Time on November 28, 2023.
- Share Reclassification: Every 15 shares of issued and outstanding common stock were reclassified into one share.
- Fractional Shares: No fractional shares were issued; holders received cash payments based on the closing price on November 28, 2023.
- Trading Adjustments: Trading commenced on a split-adjusted basis on November 29, 2023, under the existing symbol "PRAX" with a new CUSIP number (74006W 207).
- Capital Structure: The number of authorized shares and the par value ($0.0001) remained unchanged.
Guidance, Outlook, and Risks
The filing contains no new management guidance, outlook, or discussion of risks and contingencies beyond the mechanics of the reverse stock split. The Company states that the updated financial data supplements prior reports and should be read in conjunction with them.
Investor Verification Checklist
- Verify the new CUSIP number (74006W 207) for trading and record-keeping purposes.
- Confirm the cash payment received for any fractional shares resulting from the 1-for-15 split.
- Review the referenced Exhibit 99.1 for the specific updated unaudited selected financial data adjusted for the split.
- Ensure brokerage accounts reflect the adjusted share count and price effective November 29, 2023.